Literature DB >> 6895862

1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines.

K Colston, M J Colston, A H Fieldsteel, D Feldman.   

Abstract

Specific, high-affinity cytosolic receptors for 1,25-dihydroxyvitamin D3 have been demonstrated in five human cancer cell lines. The cell lines were derived from tumors of breast, lung, cervix, and melanotic and amelanotic melanomas. Binding affinity (Kd) of the receptors for 1,25-dihydroxyvitamin D3 were all approximately 0.2 nM, and receptor content ranged from 21 to 174 fmol/mg cytosol protein. The receptors from all five cell lines sedimented at 3.2S on sucrose density gradients and exhibited preferential affinity for 1,25-dihydroxyvitamin D3 compared to other vitamin D metabolites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6895862

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  Vitamin D receptor and RXR in the post-genomic era.

Authors:  Mark D Long; Lara E Sucheston-Campbell; Moray J Campbell
Journal:  J Cell Physiol       Date:  2015-04       Impact factor: 6.384

Review 2.  Skin cancer and vitamin D: an update.

Authors:  Candy Wyatt; Rachel E Neale; Robyn M Lucas
Journal:  Melanoma Manag       Date:  2015-02-25

Review 3.  Vitamin D in cutaneous carcinogenesis: part II.

Authors:  Jean Y Tang; Teresa Fu; Christopher Lau; Dennis H Oh; Daniel D Bikle; Maryam M Asgari
Journal:  J Am Acad Dermatol       Date:  2012-11       Impact factor: 11.527

4.  Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.

Authors:  Craig L Doig; Prashant K Singh; Vineet K Dhiman; James L Thorne; Sebastiano Battaglia; Michelle Sobolewski; Orla Maguire; Laura P O'Neill; Bryan M Turner; Christopher J McCabe; Dominic J Smiraglia; Moray J Campbell
Journal:  Carcinogenesis       Date:  2012-10-20       Impact factor: 4.944

Review 5.  Vitamin D receptor, a tumor suppressor in skin.

Authors:  Daniel D Bikle
Journal:  Can J Physiol Pharmacol       Date:  2014-12-08       Impact factor: 2.273

6.  Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells.

Authors:  James L Thorne; Orla Maguire; Craig L Doig; Sebastiano Battaglia; Leah Fehr; Lara E Sucheston; Merja Heinaniemi; Laura P O'Neill; Christopher J McCabe; Bryan M Turner; Carsten Carlberg; Moray J Campbell
Journal:  Nucleic Acids Res       Date:  2010-11-17       Impact factor: 16.971

7.  Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma.

Authors:  V Raina; D Cunningham; N Gilchrist; M Soukop
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

Review 8.  The vitamin D receptor: a tumor suppressor in skin.

Authors:  Daniel D Bikle
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

9.  Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.

Authors:  Sascha Abbas; Alexandra Nieters; Jakob Linseisen; Tracy Slanger; Silke Kropp; Elke Jonny Mutschelknauss; Dieter Flesch-Janys; Jenny Chang-Claude
Journal:  Breast Cancer Res       Date:  2008-04-17       Impact factor: 6.466

Review 10.  Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells.

Authors:  Prashant K Singh; Craig L Doig; Vineet K Dhiman; Bryan M Turner; Dominic J Smiraglia; Moray J Campbell
Journal:  J Steroid Biochem Mol Biol       Date:  2012-10-23       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.